Isradipine improves platelet function in hypertensives View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-01

AUTHORS

H. Sinzinger, I. Virgolini, F. Rauscha, P. Fitscha, J. O'Grady

ABSTRACT

The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension. More... »

PAGES

43-46

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00314918

DOI

http://dx.doi.org/10.1007/bf00314918

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005960838

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1531796


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Platelets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dihydropyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epoprostenol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isradipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostaglandin D2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sinzinger", 
        "givenName": "H.", 
        "id": "sg:person.0774566513.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774566513.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Virgolini", 
        "givenName": "I.", 
        "id": "sg:person.0764224033.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764224033.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rauscha", 
        "givenName": "F.", 
        "id": "sg:person.01022360525.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022360525.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "2nd Department of Internal Medicine, Polyclinic, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fitscha", 
        "givenName": "P.", 
        "id": "sg:person.052462543.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.052462543.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Vienna", 
          "id": "https://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Department of Pharmacology, University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Grady", 
        "givenName": "J.", 
        "id": "sg:person.0635300045.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635300045.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0049-3848(89)90089-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005391147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(88)90087-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023192128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(79)90202-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026392925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.42.4.562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042677578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-8703(83)90285-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049207021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.43.1.115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050987766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0262-1746(86)90196-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052160031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079966655", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992-01", 
    "datePublishedReg": "1992-01-01", 
    "description": "The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00314918", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "name": "Isradipine improves platelet function in hypertensives", 
    "pagination": "43-46", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1c64ea9fd4e4f0e40ecefaefd5fae5d98aa6a422bfc6fc2b3d6b8a0da360d163"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1531796"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00314918"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005960838"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00314918", 
      "https://app.dimensions.ai/details/publication/pub.1005960838"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130811_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00314918"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      21 PREDICATES      52 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00314918 schema:about N0aa8a36ee53b4a4f9fa4c05ad66e69d4
2 N13bb266233454bbd8b2b41abb77da54f
3 N2c928bf378c84191909df9d9b8fea363
4 N3fa0507e5cca47deaff1161f03ab9dd1
5 N43cbe9509f8847209e56b4c95a6c4528
6 N62e1422acac5437ab8de3e30b18e475b
7 N6a1936e8ed874a2886240cbf24f9f5eb
8 N92f5b7aca4254359bc3d94a93bf5c52b
9 N9c3dabbdd4e04ce5a1b4030f1a5b940a
10 Nafa230d6bfe345589610877f0f2ca412
11 Nb0a35b2f567e475996d1f8e241db843b
12 Ncd791e97f3d1424ea82ed6917d128bd8
13 Nd3f48161746e47618b70ab4f9cf49a9c
14 Ne78b0b8cfdad4b51b1ae3299bc6908df
15 Nfb5f7839a39e44d5a44a0bf12fd0d711
16 anzsrc-for:11
17 anzsrc-for:1102
18 schema:author N7bbf9982db76456a815eaf43842cede4
19 schema:citation https://app.dimensions.ai/details/publication/pub.1079966655
20 https://doi.org/10.1016/0002-8703(83)90285-5
21 https://doi.org/10.1016/0021-9150(79)90202-8
22 https://doi.org/10.1016/0021-9150(88)90087-1
23 https://doi.org/10.1016/0049-3848(89)90089-3
24 https://doi.org/10.1016/0262-1746(86)90196-4
25 https://doi.org/10.1161/01.res.42.4.562
26 https://doi.org/10.1161/01.res.43.1.115
27 schema:datePublished 1992-01
28 schema:datePublishedReg 1992-01-01
29 schema:description The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N8b1002946c8543f8a04d6f4e786f33d9
34 Nc8b2067a36cc448f81e78d15060d2469
35 sg:journal.1054337
36 schema:name Isradipine improves platelet function in hypertensives
37 schema:pagination 43-46
38 schema:productId N3a2634ef7ae44a0c84a3c31b4f6e8df0
39 N87095236cc834ea7a41360d28514f28a
40 N9f95c3af95724212a07f2673e23cbc4d
41 Na1ac132a0af444a3afce664f35d0672e
42 Nfee4e70a48d141319ea9110d9d329ce8
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005960838
44 https://doi.org/10.1007/bf00314918
45 schema:sdDatePublished 2019-04-11T13:54
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher N4f8ab4242f7b4712991e11f269647cc3
48 schema:url http://link.springer.com/10.1007/BF00314918
49 sgo:license sg:explorer/license/
50 sgo:sdDataset articles
51 rdf:type schema:ScholarlyArticle
52 N0aa8a36ee53b4a4f9fa4c05ad66e69d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Antihypertensive Agents
54 rdf:type schema:DefinedTerm
55 N13bb266233454bbd8b2b41abb77da54f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Epoprostenol
57 rdf:type schema:DefinedTerm
58 N2a175e8d0ec2496981d485893c64a9cc rdf:first sg:person.01022360525.28
59 rdf:rest N8a23c8d02e1b4103a889cbab4ffb3430
60 N2c928bf378c84191909df9d9b8fea363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Isradipine
62 rdf:type schema:DefinedTerm
63 N3a2634ef7ae44a0c84a3c31b4f6e8df0 schema:name nlm_unique_id
64 schema:value 1256165
65 rdf:type schema:PropertyValue
66 N3fa0507e5cca47deaff1161f03ab9dd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Middle Aged
68 rdf:type schema:DefinedTerm
69 N43cbe9509f8847209e56b4c95a6c4528 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Hypertension
71 rdf:type schema:DefinedTerm
72 N4c23723618b24f5ca1634dafbe1a7fb5 rdf:first sg:person.0764224033.26
73 rdf:rest N2a175e8d0ec2496981d485893c64a9cc
74 N4f8ab4242f7b4712991e11f269647cc3 schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 N62e1422acac5437ab8de3e30b18e475b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Dihydropyridines
78 rdf:type schema:DefinedTerm
79 N6a1936e8ed874a2886240cbf24f9f5eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Male
81 rdf:type schema:DefinedTerm
82 N6dde522fe9df47fbb90290fb9b255469 schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
83 rdf:type schema:Organization
84 N70c976c05a8845399d642fb69119b022 schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
85 rdf:type schema:Organization
86 N7bbf9982db76456a815eaf43842cede4 rdf:first sg:person.0774566513.24
87 rdf:rest N4c23723618b24f5ca1634dafbe1a7fb5
88 N87095236cc834ea7a41360d28514f28a schema:name readcube_id
89 schema:value 1c64ea9fd4e4f0e40ecefaefd5fae5d98aa6a422bfc6fc2b3d6b8a0da360d163
90 rdf:type schema:PropertyValue
91 N8a23c8d02e1b4103a889cbab4ffb3430 rdf:first sg:person.052462543.13
92 rdf:rest N8b114b507b45425db1cc1e12b7c0ead8
93 N8b1002946c8543f8a04d6f4e786f33d9 schema:issueNumber 1
94 rdf:type schema:PublicationIssue
95 N8b114b507b45425db1cc1e12b7c0ead8 rdf:first sg:person.0635300045.15
96 rdf:rest rdf:nil
97 N92f5b7aca4254359bc3d94a93bf5c52b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Platelet Aggregation
99 rdf:type schema:DefinedTerm
100 N98a84af807af4954a8e0901b17dca8a8 schema:name 2nd Department of Internal Medicine, Polyclinic, Vienna, Austria
101 rdf:type schema:Organization
102 N9c3dabbdd4e04ce5a1b4030f1a5b940a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Blood Platelets
104 rdf:type schema:DefinedTerm
105 N9f95c3af95724212a07f2673e23cbc4d schema:name dimensions_id
106 schema:value pub.1005960838
107 rdf:type schema:PropertyValue
108 Na1ac132a0af444a3afce664f35d0672e schema:name pubmed_id
109 schema:value 1531796
110 rdf:type schema:PropertyValue
111 Nafa230d6bfe345589610877f0f2ca412 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Analysis of Variance
113 rdf:type schema:DefinedTerm
114 Nb0a35b2f567e475996d1f8e241db843b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Prostaglandin D2
116 rdf:type schema:DefinedTerm
117 Nc8b2067a36cc448f81e78d15060d2469 schema:volumeNumber 42
118 rdf:type schema:PublicationVolume
119 Ncd791e97f3d1424ea82ed6917d128bd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Calcium Channel Blockers
121 rdf:type schema:DefinedTerm
122 Nd3f48161746e47618b70ab4f9cf49a9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Blood Pressure
124 rdf:type schema:DefinedTerm
125 Ne349209d627a4c87abed66a4a0e52a61 schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
126 rdf:type schema:Organization
127 Ne78b0b8cfdad4b51b1ae3299bc6908df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Heart Rate
129 rdf:type schema:DefinedTerm
130 Nfb5f7839a39e44d5a44a0bf12fd0d711 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 Nfee4e70a48d141319ea9110d9d329ce8 schema:name doi
134 schema:value 10.1007/bf00314918
135 rdf:type schema:PropertyValue
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
140 schema:name Cardiorespiratory Medicine and Haematology
141 rdf:type schema:DefinedTerm
142 sg:journal.1054337 schema:issn 0031-6970
143 1432-1041
144 schema:name European Journal of Clinical Pharmacology
145 rdf:type schema:Periodical
146 sg:person.01022360525.28 schema:affiliation N6dde522fe9df47fbb90290fb9b255469
147 schema:familyName Rauscha
148 schema:givenName F.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022360525.28
150 rdf:type schema:Person
151 sg:person.052462543.13 schema:affiliation N98a84af807af4954a8e0901b17dca8a8
152 schema:familyName Fitscha
153 schema:givenName P.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.052462543.13
155 rdf:type schema:Person
156 sg:person.0635300045.15 schema:affiliation https://www.grid.ac/institutes/grid.10420.37
157 schema:familyName O'Grady
158 schema:givenName J.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635300045.15
160 rdf:type schema:Person
161 sg:person.0764224033.26 schema:affiliation N70c976c05a8845399d642fb69119b022
162 schema:familyName Virgolini
163 schema:givenName I.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764224033.26
165 rdf:type schema:Person
166 sg:person.0774566513.24 schema:affiliation Ne349209d627a4c87abed66a4a0e52a61
167 schema:familyName Sinzinger
168 schema:givenName H.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774566513.24
170 rdf:type schema:Person
171 https://app.dimensions.ai/details/publication/pub.1079966655 schema:CreativeWork
172 https://doi.org/10.1016/0002-8703(83)90285-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049207021
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/0021-9150(79)90202-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026392925
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/0021-9150(88)90087-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023192128
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/0049-3848(89)90089-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005391147
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1016/0262-1746(86)90196-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052160031
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1161/01.res.42.4.562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042677578
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1161/01.res.43.1.115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050987766
185 rdf:type schema:CreativeWork
186 https://www.grid.ac/institutes/grid.10420.37 schema:alternateName University of Vienna
187 schema:name Department of Pharmacology, University of Vienna, Vienna, Austria
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...